CVE-2026-41360

OpenClaw < 2026.4.2 - Approval Integrity Bypass in pnpm dlx Local Script Binding

CVSS 5.4 MEDIUMEPSS 0.1%CWE-367

Vexday Risk Score

13Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 5.4EPSS 0.1%KEV nãoPoC —Nuclei —Metasploit —Patch referenciado

Lifecycle

23 Apr 2026Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.

CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N

Affected products

OpenClaw · OpenClaw

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859eeff https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcj https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-in-pnpm-dlx-local-script-binding